LLY Jun 2024 440.000 call
| Previous close | 344.39 |
| Open | 344.39 |
| Bid | 293.05 |
| Ask | 298.95 |
| Strike | 440.00 |
| Expiry date | 2024-06-21 |
| Day's range | 344.39 - 344.39 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
Insider MonkeyKevin O’Leary’s Stock Portfolio: 10 Stock Picks for 2024
In this article, we discuss the 10 companies to consider in the portfolio of Kevin O’Leary for 2024. If you want to skip our overview of O’Leary’s investment philosophy and learn about some more companies in his stock portfolio, go directly to Kevin O’Leary’s Stock Portfolio: 5 Stock Picks for 2024. Kevin O’Leary, affectionately known […]
- Reuters
UPDATE 2-US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss its experimental Alzheimer's disease drug, donanemab, on June 10. Donanemab has faced two separate regulatory delays in the United States, while a similar therapy by Eisai and partner Biogen, called Leqembi, received the U.S. Food and Drug Administration's approval last year. Lilly's donanemab was declined accelerated approval by the FDA in January 2023, and on March 8, the agency said it would hold a meeting of its advisers to discuss the drug, further delaying its approval.
Investor's Business DailyMutual Funds Can't Get Enough Amazon, Broadcom
Amazon stock climbs back near highs and is a mutual funds favorite. Shares gained more than 23% this year. Broadcom stock tests a key level.
